Satellos Bioscience Inc.
MSCLF
$0.49
-$0.01-1.20%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.82M | -5.61M | -6.14M | -4.36M | -6.62M |
| Total Depreciation and Amortization | 3.00K | 0.00 | 1.00K | 8.60K | 2.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 889.00K | 446.00K | 639.00K | -518.60K | 3.06M |
| Change in Net Operating Assets | 803.00K | 319.00K | -1.87M | -705.80K | 322.00K |
| Cash from Operations | -4.13M | -4.84M | -7.37M | -5.58M | -3.24M |
| Capital Expenditure | -3.00K | -3.00K | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.33M | 8.48M | -- | -8.30M | 12.97M |
| Cash from Investing | -15.33M | 8.47M | -- | -8.30M | 12.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 700.00K | 1.39M | 2.00K | 43.40M | 170.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 9.85M | -- |
| Cash from Financing | 700.00K | 1.39M | 2.00K | 38.04M | 170.00K |
| Foreign Exchange rate Adjustments | -155.00K | 484.00K | 3.00K | 297.90K | 305.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.91M | 5.51M | -7.36M | 24.46M | 10.21M |